These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 392366)

  • 1. [Characterization and comparison of the clinical and morphological changes in adriamycin cardiomyopathy].
    Bühner R; Henrichs J; Gottschalk R
    Onkologie; 1979 Feb; 2(1):24-7. PubMed ID: 392366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Daunomycin-and adriamycin-induced cardiomyopathy--relationship between dosage of drugs and histopathological findings (author's transl)].
    Yamaguchi H; Toyota S; Takahara O; Ichimaru M
    Rinsho Ketsueki; 1978 Aug; 19(8):1041-50. PubMed ID: 713049
    [No Abstract]   [Full Text] [Related]  

  • 3. [Congestive cardiomyopathy after doxorubicin (adriamycin)author's transl)].
    Kaduk B; Seiler G
    Dtsch Med Wochenschr; 1977 Dec; 102(49):1813-7. PubMed ID: 271071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin (adriamycin) cardiomyopathy.
    Saltiel E; McGuire W
    West J Med; 1983 Sep; 139(3):332-41. PubMed ID: 6356608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endomyocardial biopsy as a method of surveilling adriamycin cardiac toxicity. 28 biopsies in 26 patients].
    Bouhour JB; Petitier H; Delajartre AY; Fumoleau P; Rozo L; Nicolas G
    Arch Mal Coeur Vaiss; 1983 Nov; 76(11):1277-83. PubMed ID: 6419695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy.
    Bristow MR; Mason JW; Billingham ME; Daniels JR
    Am Heart J; 1981 Oct; 102(4):709-18. PubMed ID: 7282516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin cardiomyopathy. Fatal outcome of general anaesthesia in a child with adriamycin cardiomyopathy.
    McQuillan PJ; Morgan BA; Ramwell J
    Anaesthesia; 1988 Apr; 43(4):301-4. PubMed ID: 3377152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with probucol prevents adriamycin-induced cardiomyopathy.
    Singal PK; Siveski-Iliskovic N; Hill M; Thomas TP; Li T
    J Mol Cell Cardiol; 1995 Apr; 27(4):1055-63. PubMed ID: 7563102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.
    Jaenke RS
    Cancer Res; 1976 Aug; 36(8):2958-66. PubMed ID: 1277204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from adriamycin-induced cardiomyopathy in rats.
    Shug AL
    Z Kardiol; 1987; 76 Suppl 5():46-52. PubMed ID: 3433883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin cardiomyopathy.
    Sanyal SK; Johnson WW
    Ann Intern Med; 1978 Jul; 89(1):136-7. PubMed ID: 666159
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiotoxic side effects of adriamycin].
    Brockmann B; Matthias M
    Z Arztl Fortbild (Jena); 1983; 77(5):209-11. PubMed ID: 6858220
    [No Abstract]   [Full Text] [Related]  

  • 13. Anthracycline cardiotoxicity: recognition, management, and avoidance.
    Mason JW
    Compr Ther; 1979 Jul; 5(7):64-8. PubMed ID: 477286
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathological features of cantharidin-induced toxic cardiomyopathy: lack of correlation between electron-microscopic and histopathologic myocardial damage.
    Friesen JM; Ferris JA; Rabkin SS; Fung HY
    Forensic Sci Int; 1979; 13(3):187-92. PubMed ID: 88399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin-induced cardiomyopathy. A rat model.
    Czarnecki A; Hinek A; Sołtysiak-Pawluczuk D
    Pol J Pharmacol Pharm; 1986; 38(2):171-7. PubMed ID: 3748888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics and acute signs of cardiac toxicity during doxorubicin therapy].
    Lenzhofer R; Schneeweiss B; Rameis H; Eichler H; Graninger W; Dittrich C; Dudczak R; Ganzinger U; Gasic S; Moser K
    Wien Klin Wochenschr; 1983 Jan; 95(2):52-5. PubMed ID: 6858169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenylamine inhibition of adriamycin-induced cardiomyopathy in mice.
    Milei J; Bolomo NJ; Marantz A
    Medicina (B Aires); 1982; 42(4):409-14. PubMed ID: 15171023
    [No Abstract]   [Full Text] [Related]  

  • 18. Pixantrone (BBR 2778) has reduced cardiotoxic potential in mice pretreated with doxorubicin: comparative studies against doxorubicin and mitoxantrone.
    Cavalletti E; Crippa L; Mainardi P; Oggioni N; Cavagnoli R; Bellini O; Sala F
    Invest New Drugs; 2007 Jun; 25(3):187-95. PubMed ID: 17285358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric study of myocardial changes during doxorubicin-induced cardiomyopathy in mice.
    van der Vijgh WJ; van Velzen D; van der Poort JS; Schlüper HM; Mross K; Feijen J; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1603-8. PubMed ID: 3208804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined cardiotoxicity of adriamycin and x-radiation.
    Fajardo LF; Eltringham JR; Steward JR
    Lab Invest; 1976 Jan; 34(1):86-96. PubMed ID: 1246126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.